Abstract
Context: Maternal vitamin D level is an important determinant of pregnancy and child health outcomes. Exposure to air pollution is suspected to increase the risk of vitamin D deficiency, but the evidence is scarce. Objective: We investigated the association between air pollution during pregnancy and maternal vitamin D levels. Methods: A total of 15 935 pregnant women from 5 birth cohorts in Europe and the United States were included. Averaged concentrations of nitrogen oxides, fine and coarse particles, and composition of fine particles from conception until vitamin D measurement were estimated at participants' residential addresses using land-use regression or other spatiotemporal models. Cohorts measured vitamin D as 25(OH)D or 25(OH)D3 levels in serum or plasma at early or mid-pregnancy. We defined suboptimal vitamin D levels as levels below 20 ng/mL. We performed logistic regression models for each cohort to estimate the association between air pollution exposure and suboptimal vitamin D levels and pooled cohort-specific estimates in a random-effect meta-analysis. Models were adjusted for sociodemographic and lifestyle characteristics and month of conception. Results: We found an association between particulate matter (PM)2.5 and higher odds of suboptimal vitamin D levels (ie, below 20 ng/mL) (odds ratio per 5 μg/m3 increase in PM2.5, 1.43; 95% CI: 1.02, 1.99). There was no association between other air pollutant exposure and vitamin D levels. Conclusion: PM2.5 exposure might contribute to suboptimal levels of vitamin D in pregnancy. Reducing air pollution exposure should be a priority because vitamin D deficiency may adversely influence offspring development.
Original language | English |
---|---|
Pages (from-to) | 1410–1418 |
Number of pages | 9 |
Journal | Journal of Clinical Endocrinology and Metabolism |
Volume | 110 |
Issue number | 5 |
Early online date | 13 Jun 2024 |
DOIs | |
Publication status | Published - May 2025 |
Bibliographical note
Publisher Copyright:© 2024 The Author(s). All rights reserved.
Funding
The Amsterdam Born Children and Their Development Study was supported by the Netherlands Organization for Health Research and Development, Public Health Service Amsterdam, and the Amsterdam UMC. Core support for Born in Bradford (BiB) is also provided by the Wellcome Trust (WT101597MA, UK). The BiB study is only possible because of the enthusiasm and commitment of the children and parents in BiB. We are grateful to all the participants, health professionals, schools, and researchers who have made BiB happen. BiB receives funding from the ESRC/MRC, the Wellcome Trust (WT101597MA), and the National Institute for Health Research Yorkshire and Humber ARC (reference: NIHR20016).The Generation R Study was supported by the Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; the Netherlands Organization for Health Research and Development; the Netherlands Organization for Scientific Research; and the Ministry of Health, Welfare and Sport, The Netherlands. The Generation R Study was conducted by the Erasmus Medical Center in close collaboration with the Faculty of Social Sciences of the Erasmus University Rotterdam, the Municipal Health Service Rotterdam area, Rotterdam, and the Stichting Trombosedienst & Artsenlaboratorium Rijnmond, Rotterdam. H.T. is supported by a grant from the Netherlands Organization for Health Research and Development (ZonMW 016.VICI.170.200). H.M. was supported by the Stichting Volksbond Rotterdam, the Netherlands Organization for Health Research and Development [Aspasia grant No.015.016.056], and this study received funding from the European Union's Horizon 2020 re-search and innovation program under grant agreement n.101057390 (HappyMums Project).Infancia y Medio Ambiente was funded by grants from UE (FP7-ENV-2011 cod 282957 and HEALTH.2010.2.4.5-1 and cod 874583), Spain: from Instituto de Salud Carlos III (Red INMA G03/176 and CB06/02/0041), FIS-FEDER: PI03/1615, PI04/1509, PI04/1112, PI04/1931, PI04/2018, PI05/1079, PI05/1052, PI06/0867, PI09/00090, PI06/1213, PI09/02647, PI13/02187, PI09/02311, PI11/01007, PI11/ 02591, PI11/02038, PI13/02429, PI07/0314, PI13/1944, PI13/2032, PI14/00891, PI14/01687, PI16/1288, PI17/ 00663, PI19/1338 and PI23/1578; Miguel Servet-FEDER CP11/00178, CP15/00025, CPII16/00051, CPII18/00018, MS20/0006), Spanish Ministry of Universities (Margarita Salas Grant MS21-133, grant CAS21/00008), Generalitat Valenciana (CIAICO/2021/132, BEST/2020/059, and AICO 2020/285), FISABIO (UGP 15-230, UGP-15-244, and UGP-15-249), and Alicia Koplowitz Foundation 2017 CIBERESP, Fundacion Cajastur, Universidad de Oviedo, Department of Health of the Basque Government (2005 111093, 2009111069, 2013111089 and 2015111065), and the Provincial Government of Gipuzkoa (DFG06/002, DFG08/001 and DFG15/221), annual agreements with the municipalities of the study area (Zumarraga, Urretxu, Legazpi, Azkoitia y Azpeitia y Beasain), and Generalitat de Catalunya-CIRIT 1999SGR 00241. This study received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 874583 (ATHLETE project). We acknowledge support from the grant CEX2018-000806-S funded by MCIN/AEI/ 10.13039/5011 00011033, and support from the Generalitat de Catalunya through the CERCA Program.Project Viva was funded by grants R01 HD 034568, UH3 OD023286, and R24 ES030894 from the US National Institutes of Health.
Funders | Funder number |
---|---|
Netherlands Organization for Health Research and Development | ZonMW 016.VICI.170.200 |
Public Health Service Amsterdam | |
Amsterdam UMC | |
Wellcome Trust, UK | WT101597MA |
ESRC/MRC | |
Wellcome Trust | WT101597MA |
National Institute for Health Research Yorkshire and Humber ARC | NIHR20016 |
Erasmus Medical Center, Rotterdam | |
Erasmus University, Rotterdam | |
Netherlands Organization for Scientific Research | |
Ministry of Health, Welfare and Sport, The Netherlands | |
Stichting Volksbond Rotterdam | |
Netherlands Organization for Health Research and Development | 015.016.056 |
European Union | 101057390, 874583 |
UE | FP7-ENV-2011 cod 282957, HEALTH.2010.2.4.5-1, cod 874583 |
Instituto de Salud Carlos III | Red INMA G03/176, CB06/02/0041 |
FIS-FEDER | PI03/1615, PI04/1509, PI04/1112, PI04/1931, PI04/2018, PI05/1079, PI05/1052, PI06/0867, PI09/00090, PI06/1213, PI09/02647, PI13/02187, PI09/02311, PI11/01007, PI11/ 02591, PI11/02038, PI13/02429, PI07/0314, PI13/1944, PI13/2032, PI14/00891, PI14/01687, PI16/1288, PI17/ 00663, PI19/1338, PI23/1578 |
Miguel Servet-FEDER | CP11/00178, CP15/00025, CPII16/00051, CPII18/00018, MS20/0006 |
Spanish Ministry of Universities | MS21-133, CAS21/00008 |
Generalitat Valenciana | CIAICO/2021/132, BEST/2020/059, AICO 2020/285 |
FISABIO | UGP 15-230, UGP-15-244, UGP-15-249 |
Alicia Koplowitz Foundation | 2017 CIBERESP |
Fundacion Cajastur | |
Universidad de Oviedo | |
Department of Health of the Basque Government | 2005 111093, 2009111069, 2013111089, 2015111065 |
Provincial Government of Gipuzkoa | DFG06/002, DFG08/001, DFG15/221 |
Generalitat de Catalunya | CIRIT 1999SGR 00241 |
MCIN/AEI | CEX2018-000806-S |
Generalitat de Catalunya | |
US National Institutes of Health | R01 HD 034568, UH3 OD023286, R24 ES030894 |
Keywords
- air quality
- particulate matter
- pregnancy
- vitamin D